https://orcid.org/0000-0003-1223-1589
Citations (7)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Javier Velasco-Alvarez. (2022) Significant Discrepancies in “Functional Characterization of Undenatured Type II Collagen Supplements: Are They Interchangeable?”: A Rejoinder. Journal of Dietary Supplements 19:6, pages 747-748.
Read now
Read now
Articles from other publishers (6)
Emre Sahin, Cemal Orhan, Fusun Erten, Zainulabedin Saiyed, Elnaz Karimian Azari, Shane Durkee & Kazim Sahin. (2023) The effect of oral administration of undenatured type II collagen on monosodium iodoacetate-induced osteoarthritis in young and old rats. Scientific Reports 13:1.
Crossref
Crossref
Ana Zapata & Rocio Fernández-Parra. (2023) Management of Osteoarthritis and Joint Support Using Feed Supplements: A Scoping Review of Undenatured Type II Collagen and Boswellia serrata. Animals 13:5, pages 870.
Crossref
Crossref
O. A. Shavlovskaya, I. V. Sarvilina, O. A. Gromova, M. N. Sharov, I. A. Bokova, Y. S. Prokofieva & N. I. Shavlovskiy. (2022) Pharmacotherapy of pain in musculoskeletal diseases: evolution and revolution of views. Neurology, Neuropsychiatry, Psychosomatics 14:4, pages 87-95.
Crossref
Crossref
O. A. Gromova, I. Yu. Torshin, A. M. Lila & O. A. Shavlovskaya. (2022) On the prospects for the use of undenatured type II collagen in the treatment of osteoarthritis and other joint diseases. Modern Rheumatology Journal 16:4, pages 111-116.
Crossref
Crossref
O.A. Shavlovskaya. (2022) Complex effects of physical exertion with dietary supplements Cartilox in pain syndrome effectiveness and safety evaluation. Voprosy kurortologii, fizioterapii i lechebnoi fizicheskoi kul'tury 99:4, pages 20.
Crossref
Crossref
O.A. Shavlovskaya, O.A. Gromova & I.Yu. Torshin. (2022) Points of undenatured type II collagen application in musculoskeletal pain syndromes treatment. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 122:11, pages 40.
Crossref
Crossref